Unlock instant, AI-driven research and patent intelligence for your innovation.

Long-acting preparation for tatin medicine

A drug and statin technology, applied in the field of transdermal drug delivery system and subcutaneous implantation drug delivery system of statins, can solve the problems of forgetting to take, affecting the treatment effect, side effects and the like

Inactive Publication Date: 2006-05-31
ANHUI HUIKE PHARMA
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And daily oral administration has the following disadvantages: First, after taking the medicine, due to the first-pass metabolism (first-pass metabolism) in the liver and the elimination of the digestive system, the bioavailability (bio-availability) of statins and can reach The overall circulation effectiveness (general circulation) is very low
However, more and more results show that statins have side effects that cannot be ignored on the liver, kidneys, and muscle tissue of the human body. Reducing the dosage of statins is an urgent task at present
Second, it is very easy to forget to take it and affect the treatment effect
Although the research on statins has always been a very hot topic, one of the most important research and development topics, the field of long-acting preparations, has not been reported so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-acting preparation for tatin medicine
  • Long-acting preparation for tatin medicine
  • Long-acting preparation for tatin medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Example 1: Preparation of Transdermal Drug Delivery System or Subcutaneous Implanted Drug Delivery System

[0064] 1. Under nitrogen protection, 430 grams of ethanol and 215 grams of ethyl acetate are added to 1960 grams of polyacrylic polymer material (Durotak 387-2287, 1004 grams of solids) solution, stirred at room temperature until well mixed.

[0065] 2. According to the ratio shown in Table 1, add statins, substances used to prevent statins from crystallizing in the storage drug depot, and antioxidants. If it is used in a transdermal drug delivery system, a viscosity enhancer and a skin penetration accelerator are additionally added. If it is used for subcutaneous implantation of drug delivery system, some hydrogel can be added. The resulting mixture was stirred evenly and then put into a closed barrel for use to prevent the solvent from volatilizing.

[0066]

ingredients

transdermal administration

subcutaneous implant

Samp...

Embodiment 2

[0074] Example 2 In vitro drug permeability test

[0075] In vitro drug permeability tests were performed using human skin. The skin was clamped onto a diffusion cell (Franz cell). A single-layer simple adhesive patch (4.8 cm2, 1.0 mm thick storage drug storehouse, simvastatin) was pasted on the skin, and the drug penetration was measured at 37 ° C. The drug receiving medium was 1.0% sodium chloride aqueous solution. Methods Determination of cumulative permeation dose. The results are shown in Table 2:

[0076] time (hours)

Embodiment 3

[0077] Synthesis of simvastatin derivatives of embodiment 3 formula (2)

[0078]Under nitrogen protection, 16.0 g of dried simvastatin was suspended in 300 ml of dichloromethane. The white solid disappeared quickly and dissolved to give a clear solution. After cooling to 5-10°C, 0.5 molar equivalents of lithium bromide, 1.3 molar equivalents of triethylammonia, and 1.4 molar equivalents of 2,2-dimethyl-butyryl chloride were added. After the reaction mixture was stirred under nitrogen for 0.5 to one hour, the reaction was stirred at room temperature. After the reaction was completed, 100 ml of water was added, and the organic layer was separated after stirring for 30 minutes. The organic layer was washed once with saturated brine (100 ml), washed four times with saturated aqueous sodium bicarbonate solution (100 ml each time), washed twice with saturated brine (100 ml each time), dried with sodium sulfate, and filtered to evaporate the solvent Finally, the simvastatin deriva...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
thicknessaaaaaaaaaa
Login to View More

Abstract

A durable tatin kind of medicines, that is, the percutaneous absorption system and subcutaneous implantation system of tatin kind of medicines is disclosed. Its products may be medicinal pickings, non-decompsing high-molecular film, and medicine kernel.

Description

Field of invention: [0001] The present invention is a new preparation capable of releasing statins for a long period of time so that statins can have better curative effect, more precisely, it is a transdermal delivery system and a subcutaneous implantation delivery system of statins. Background of the invention: [0002] Statins, hydroxymethylglutaryl coenzyme A reductase inhibitors (HMG-CoA-RI), are one of the major discoveries of human beings in the late 20th century, and have a good preventive effect on cardiovascular and cerebrovascular diseases. The main feature of statins is to reduce endogenous cholesterol synthesis, prevent the occurrence and development of atherosclerosis, and are suitable for primary hypercholesterolemia. In addition to being used as lipid-lowering drugs, statins are now found to have certain effects on osteoporosis, Alzheimer's disease, heart disease, organ transplantation, stroke and diabetes. [0003] Currently, statins are mainly administered...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61K9/10A61K31/357A61K45/00A61P3/06A61P3/10A61P19/10A61P25/28A61P37/06
CPCA61K9/0024A61K9/7061A61K9/7084A61K31/00A61K31/22A61K31/351A61K31/366A61K31/40A61K31/405A61K31/47A61K31/505A61K47/10A61K47/32A61P19/10A61P25/28A61P3/06A61P37/06A61P3/10
Inventor 朱作霖叶红平孙萌
Owner ANHUI HUIKE PHARMA